Clinical Trials Market: By Clinical Trial Phase, By Disease Type, By Design, By End user and Geography

Clinical Trials Market Size, Share, Growth, Trends, and Global Industry Analysis: By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase 3, Phase 4), By Disease Type (Infectious diseases, Cancer, Diabetes, Autoimmune disorders, Inflammatory diseases, Cardiovascular diseases, Haematological disorders, Neurological disorders, Dermatology, Others), By Design (Observational trials, Interventional trials, Expanded access trials), By End user (Clinical research organizations, Pharmaceutical and biotechnology companies, Research institutes, Others) and Region

Clinical Trials Market size was valued at US$ 46.8 billion in the year 2023 and is anticipated to grow US$ 70.23 Bn by 2030 at a CAGR of 7.5% from 2024-2030. Clinical trials are research studies primarily performed on humans to get data about the safety and efficacy of newer biomedical interventions including novel devices, vaccines, drugs, and treatments. Generally, clinical trials are regulated by the ethics committees and health authorities. On the broad base, clinical trials are carried out to determine the overall pharmacokinetic and pharmacodynamic properties of the products. Clinical trials are carried out under various phases such as Phase 0 to Phase 3 and Phase 4 is carried out for a post-marketing study of the products.

The product will be recalled if it fails at any stage of the clinical trial. Geographically, the Clinical Trials market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. for the development of capabilities in infectious diseases and vaccines. Clinical trials are research investigations in which people volunteer to test medical equipment or pharmaceuticals to figure out how to cure particular diseases or problems. They are carried out to diagnose, detect, and prevent certain diseases. To carry out the testing method, each clinical trial has its own set of protocols and action plans. Clinical trials are used to gather information about the efficacy, safety, and efficacy of pharmaceuticals and medical treatments on animals and humans.

Clinical Trials Market Key Developments:

In June 2017, Audax private equity acquired the Altasciences Clinical Researches for organizing the clinical trials.
In September 2016, Icon Plc has acquired Clinical Research Management, Inc

Download Free Sample

Global Clinical Trials Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.5%

Largest Market

North America

Fastest Growing Market

Europe

Clinical Trials Market Dynamics

Increase in the prevalence of chronic diseases and entry of newer diseases might propel the innovation of novel drugs leads to bolster the clinical trials market. Acquisitions & mergers, collaborations, and joint ventures between the pharmaceutical and biotechnology companies with clinical research organizations are helping to drive the revenue growth of clinical trials market. For instance, in September 2015, Chiltern acquired the theorem clinical for strengthening the facilities for clinical trials. Similarly, in June 2017, ProPharma group acquired the Drug Safety Solutions for the development of clinical trial facilities. clinical trials market is in the developed stage owing increase in the R&D activities and innovation of newer biological products and medical devices in the market.

North-America Got Significant Share

Clinical Trials Market Regional Analysis

Increase in the R&D activities for chronic disorders, innovation of novel molecules, the presence of a huge number of biopharmaceutical companies, an increase in healthcare expenditure is anticipated to propel the North America clinical trials market. Europe clinical trials market is in advanced stage attributed to increase in the regulatory requirements for product approvals, increase in the R&D activities in Germany, U.K. and Spain owing to presence of large number of R&D firms, increase in the prevalence of chronic diseases such as cancer, diabetes due to change in lifestyle, and rise in number of clinical research organizations propel the market over the forecast period. However, Asia Pacific exhibiting significant growth owing to increase in the clinical trials majorly in China, India, South Korea, Japan, and among others, less expenditure for clinical trials, and availability of diseased population in Asia Pacific region are expected to drive the market over the forecast period.

Latin America

Europe

Asia Pacific

Middle East

North America

Global Clinical Trials Market Segmentation Analysis

Report Benchmarks	Details
Report Study Period	2024-2030
Market CAGR	7.5%
By Trial Phase	Phase 0 Phase 1 Phase 2 Phase 3 Phase 4
By Disease Type	Infectious diseases Cancer Diabetes Autoimmune disorders Inflammatory diseases Cardiovascular diseases Haematological disorders Neurological disorders Dermatology Others
By Study Design	Observational trials Interventional trials Expanded access trials
By End User	Clinical research organizations Pharmaceutical and biotechnology companies Research institutes Others

Key Features of the Report

The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments, and start-up details that are actively working in the market
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The clinical trials market size was valued at US$ 46.8 billion in 2023

The clinical trials market key players are: Charles River Laboratories International Kendle International Parexel International Corporation Chiltern International Ltd Omnicare Healthcare Co. Audax Group Laboratory Corporation of America Holdings

The clinical trials market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

Executive Summary
Global Clinical Trials Market Introduction
- Global Clinical Trials Market Taxonomy
- Global Clinical Trials Market Definitions
  - Clinical Trial Phase
  - Disease Type
  - Study Design
  - End User

Global Clinical Trials Market Dynamics
- Drivers
- Restraints
- Opportunities/Unmet Needs of the Market
- Trends
- Global Clinical Trials Market Dynamic Factors - Impact Analysis
- Global Clinical Trials Market Competition Landscape
- Epidemiology
Global Clinical Trials Market Analysis,2019 - 2023 and Forecast, 2024 - 2030
- Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%)
- Market OpportunityAnalysis
Global Clinical Trials Market, By Clinical Trial Phase, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
- Phase 0
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Phase 1
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Phase 2
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Phase 3
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Phase 4
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Clinical Trials Market Forecast, By Disease Type,2019 - 2023 and Forecast, 2024 - 2030
- Infectious diseases
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Cancer
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Diabetes
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Autoimmune disorders
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Inflammatory diseases
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Cardiovascular diseases
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Haematological disorders
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Neurological disorders
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Dermatology
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Others
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Clinical Trials Market Forecast, By Study Design, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
- Observational trials
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Interventional trials
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Expanded access trials
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Clinical Trials Market Forecast, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
- Clinical research organizations
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Pharmaceutical and biotechnology companies
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Research institutes
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Others
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Clinical Trials Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
- North America
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Europe
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Asia-Pacific
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Latin America
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Middle East and Africa
  - Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Global Clinical Trials Market - Opportunity Analysis Index, By Clinical Trial Phase, By Disease Type, By Study Design, By End User, and Region, 2024 - 2030
North America Clinical Trials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
- Clinical Trial Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
  - Phase 0
  - Phase 1
  - Phase 2
  - Phase 3
  - Phase 4
- Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Infectious diseases
  - Cancer
  - Diabetes
  - Autoimmune disorders
  - Inflammatory diseases
  - Cardiovascular diseases
  - Haematological disorders
  - Neurological disorders
  - Dermatology
  - Others
- Study Design Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Observational trials
  - Interventional trials
  - Expanded access trials
- End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Clinical research organizations
  - Pharmaceutical and biotechnology companies
  - Research institutes
  - Others
- Country Analysis 2018 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  - US
  - Canada
- North America Clinical Trials Market - Opportunity Analysis Index, By Clinical Trial Phase, By Disease Type, By Study Design, By End User, and Country, 2024 - 2030
- North America Clinical Trials Market Dynamics Trends
Europe Clinical Trials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
- Clinical Trial Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
  - Phase 0
  - Phase 1
  - Phase 2
  - Phase 3
  - Phase 4
- Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Infectious diseases
  - Cancer
  - Diabetes
  - Autoimmune disorders
  - Inflammatory diseases
  - Cardiovascular diseases
  - Haematological disorders
  - Neurological disorders
  - Dermatology
  - Others
- Study Design Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Observational trials
  - Interventional trials
  - Expanded access trials
- End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Clinical research organizations
  - Pharmaceutical and biotechnology companies
  - Research institutes
  - Others
- Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  - Germany
  - UK
  - France
  - Spain
  - Italy
  - Russia
  - Poland
  - Rest of Europe
- Europe Clinical Trials Market - Opportunity Analysis Index, By Clinical Trial Phase, By Disease Type, By Study Design, By End User, and Country, 2024 - 2030
- Europe Clinical Trials Market Dynamics â€“ Trends
Asia-Pacific Clinical Trials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
- Clinical Trial Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
  - Phase 0
  - Phase 1
  - Phase 2
  - Phase 3
  - Phase 4
- Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Infectious diseases
  - Cancer
  - Diabetes
  - Autoimmune disorders
  - Inflammatory diseases
  - Cardiovascular diseases
  - Haematological disorders
  - Neurological disorders
  - Dermatology
  - Others
- Study Design Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Observational trials
  - Interventional trials
  - Expanded access trials
- End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Clinical research organizations
  - Pharmaceutical and biotechnology companies
  - Research institutes
  - Others
- Country Analysis2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  - Japan
  - China
  - India
  - ASEAN
  - Australia & New Zealand
  - Rest of Asia-Pacific
- Asia-Pacific Clinical Trials Market - Opportunity Analysis Index, By Clinical Trial Phase, By Disease Type, By Study Design, By End User, and Country, 2024 - 2030
- Asia-Pacific Clinical Trials Market Dynamics Trends
Latin America Clinical Trials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
- Clinical Trial Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
  - Phase 0
  - Phase 1
  - Phase 2
  - Phase 3
  - Phase 4
- Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Infectious diseases
  - Cancer
  - Diabetes
  - Autoimmune disorders
  - Inflammatory diseases
  - Cardiovascular diseases
  - Haematological disorders
  - Neurological disorders
  - Dermatology
  - Others
- Study Design Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Observational trials
  - Interventional trials
  - Expanded access trials
- End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Clinical research organizations
  - Pharmaceutical and biotechnology companies
  - Research institutes
  - Others
- Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  - Brazil
  - Mexico
  - Argentina
  - Venezuela
  - Rest of Latin America
- Latin America Clinical Trials Market - Opportunity Analysis Index, By Clinical Trial Phase, By Disease Type, By Study Design, By End User, and Country, 2024 - 2030
- Latin America Clinical Trials Market Dynamics Trends
Middle East and Africa Clinical Trials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
- Clinical Trial Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
  - Phase 0
  - Phase 1
  - Phase 2
  - Phase 3
  - Phase 4
- Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Infectious diseases
  - Cancer
  - Diabetes
  - Autoimmune disorders
  - Inflammatory diseases
  - Cardiovascular diseases
  - Haematological disorders
  - Neurological disorders
  - Dermatology
  - Others
- Study Design Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Observational trials
  - Interventional trials
  - Expanded access trials
- End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Clinical research organizations
  - Pharmaceutical and biotechnology companies
  - Research institutes
  - Others
- Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  - Gulf Cooperation Council (GCC) Countries
  - Israel
  - South Africa
  - Rest of MEA
- MEA Clinical Trials Market - Opportunity Analysis Index, By Clinical Trial Phase, By Disease Type, By Study Design, By End User, and Country, 2024 - 2030
- MEA Clinical Trials Market Dynamics Trends
Competition Landscape
- Strategic Dashboard of Top Market Players
- Company Profiles (Introduction, Financial Analysis, Clinical Trial Phase& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  - Charles River Laboratories International, Inc. (U.S.)
  - Icon Plc. (Ireland)
  - Quintiles IMS Holdings, Inc. (U.S.)
  - Kendle International Inc. (U.S.)
  - Parexel International Corporation (U.S.)
  - Chiltern International Ltd. (U.K.)
  - Omnicare Healthcare Co. (U.S.)
  - Audax Group (U.S.)
  - Laboratory Corporation of America Holdings (U.S.)
  - ProPharma Group (U.S.)

Research Methodology
Key Assumptions and Acronyms

Key Market Players

Charles River Laboratories International
Kendle International
Parexel International Corporation
Chiltern International Ltd
Omnicare Healthcare Co.
Audax Group
Laboratory Corporation of America Holdings

Related Industry Reports

Egypt Diabetes Devices Market

Lithuania Surgical Equipment Market

Antimicrobials Market

Cancer Therapy Market